ReviewMaterials today. Bio2025
Harnessing light: Synthesis, mechanisms, and pre-clinical biomedical applications of stimuli-responsive multiscale composites.
Review in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Shattering the "golden armor": A natural supramolecular nanoplatform for optical virulence modulation and MRSA keratitis therapy.Materials today. Bio · 2026Article
- Microenvironment-Responsive Drug Delivery Systems for Ocular Surface Diseases: Mechanisms, Applications, and Translational Challenges.Small science · 2026Review
- Light-Triggered and Sustained Delivery of Dexamethasone Using Chitosan-Coated PLGA Nanoparticles for Posterior Eye Disease Treatment.ACS omega · 2026Article
- Stimuli-responsive 4D-bioprinted constructs for musculoskeletal tissue regeneration: Shape-morphing mechanisms, cell-laden bioink engineering, and preclinical outcomes.Regenerative therapy · 2026Review
- Spatiotemporally programmed tissue regeneration via visible-light-responsive hydrogels: Biosafety-oriented design and applications.Materials today. Bio · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Smart multiscale composites with stimuli-responsive versatility have significantly advanced the field of biomedical science by providing precise spatiotemporal control over modulating, diagnostic, and therapeutic functions. Light-responsive composite (LRC) systems, in particular, present unique advantages owing to their non-invasive nature, bio-favorable features, high accuracy, and capacity for real-time modulation. As a safe external stimulus, light can be manipulated to modify the chemical and biochemical behavior of material composites, thus offering considerable potential within the domain of photo-pharmacology. Consequently, researchers have developed multifunctional platforms for a broad spectrum of biomedical applications, ranging from bioimaging to wound healing, by integrating light-responsive components, such as photoinitiators, luminescent/plasmonic nanoparticles, polymers, hydrogels, and hybrid scaffolds, into composite systems. Despite the substantial proliferation of original research articles in recent years, there exists a notable deficiency in comprehensive frameworks or strategic blueprints that encompass these advancements. This timely review seeks to elucidate recent progress in the realm of LRC materials, with a focus on their design principles, activation mechanisms, and emerging applications within biomedicine. Herein, a variety of multidimensional composites are discussed, including two-/one-dimensional tissue engineering/phototherapeutic platforms and zero-dimensional molecular imaging agents. Nonetheless, the exploration of these varied light-responsive materials is articulated in a manner accessible to both general and expert audiences, ensuring clarity and comprehension of complex mechanisms. Furthermore, this review addresses the considerations and specific challenges pertinent to toxicity, reproducibility/scalability, as well as clinical transitions, contributing to a deeper understanding of the potential of these innovative material composites in practical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.